Showing results (91-100 of 646) with videos related to
Sort By:
Pageof 65
Hemasphere|December 18, 2024
Proliferating CLL cells express high levels of CXCR4 and CD5Daniel Friedman, Drshika P Mehtani, Jennifer B Vidler, et al.Hemasphere|December 16, 2024
Expression profile of Bcl-2 family proteins in newly diagnosed multiple myeloma patientsCristina De Ramón, Elizabeta A Rojas, Irena Misiewicz-Krzeminska, et al.Hemasphere|February 4, 2025
Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressureMira Kusterer, Mari Lahnalampi, Minna Voutilainen, et al.Hemasphere|March 14, 2025
Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conferenceLucia de Franceschi, Franco Locatelli, David Rees, et al.Hemasphere|March 10, 2025
Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLAKatrin S Kurz, Sophia Steinlein, Markus Kreuz, et al.Hemasphere|January 24, 2025
Combining SKY92 gene expression profiling and FISH (according to R2-ISS) defines ultra-high-risk Multiple MyelomaXiang Zhou, Annika Hofmann, Benedict Engel, et al.Hemasphere|January 17, 2025
Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)Martijn P T Ernst, Jurjen Versluis, Peter J M Valk, et al.Hemasphere|September 5, 2024
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upKai Hübel, Mark Bower, Igor Aurer, et al.Hemasphere|August 23, 2024
Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphomaInna Y Gong, Daisy Tran, Samuel Saibil, et al.Pageof 65